1.
Journal of Integrative Medicine
;
(12): 405-15, 2013.
Artículo
en Inglés
| WPRIM
| ID: wpr-671832
RESUMEN
To test if myricanone (C21H24O5), a cyclic diarylheptanoid, has anticancer effects on two different cancer cell lines HeLa and PC3. The present study was conducted with a note on the drug-DNA interaction and apoptotic signalling pathway.